No phaseCompletedHealthspan endpoint

A Clinical Trial for the Evaluation of the Efficacy and Safety of Policosanol in Improving Cognitive Function

A 12-week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of Policosanol on subjects who have Subjective memory loss

Sponsor
Raydel Korea
Enrollment
150 planned
Conditions
Symptoms, signs and abnormal clinical and laboratory findings, NEC
Ages
adults, older adults
Registry
KCT0012761

Full record on CRiSSource: WHO ICTRP, processed October 5, 2026

Primary outcomes

  • ADAS-Cog 11(The Alzheimer's Disease Assessment Scale–Cognitive Subscale, 11-item version) total score
  • ADAS-Cog 11(The Alzheimer's Disease Assessment Scale–Cognitive Subscale, 11-item version) memory domain score
  • ADAS-Cog 11(The Alzheimer's Disease Assessment Scale–Cognitive Subscale, 11-item version) language/performance domain score
  • Visual C.P.T(Visual Continuous Performance Test)

History

  1. Registered

  2. Last registry update

  3. Study completion

  4. Started